Does AMIKACIN Cause Product distribution issue? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Product distribution issue have been filed in association with AMIKACIN (ARIKAYCE). This represents 0.2% of all adverse event reports for AMIKACIN.
24
Reports of Product distribution issue with AMIKACIN
0.2%
of all AMIKACIN reports
6
Deaths
17
Hospitalizations
How Dangerous Is Product distribution issue From AMIKACIN?
Of the 24 reports, 6 (25.0%) resulted in death, 17 (70.8%) required hospitalization.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIKACIN. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does AMIKACIN Cause?
Cough (1,472)
Off label use (1,447)
Dyspnoea (1,367)
Hospitalisation (1,325)
Therapy interrupted (1,283)
Drug ineffective (1,275)
Death (1,005)
Dysphonia (914)
Product dose omission issue (677)
Fatigue (602)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which AMIKACIN Alternatives Have Lower Product distribution issue Risk?
AMIKACIN vs AMILORIDE
AMIKACIN vs AMILORIDE\HYDROCHLOROTHIAZIDE
AMIKACIN vs AMINO ACIDS
AMIKACIN vs AMINO ACIDS, SOURCE UNSPECIFIED
AMIKACIN vs AMINO ACIDS\ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM HEPTAHYDRATE\POTASSIUM\SODIUM\SODIUM GLYCEROPHOSPHATE ANHYDROUS\SOYBEAN OIL